Dirk Thye, Quince Therapeutics CEO
Quince Therapeutics sets up poison pill with 'anti-takeover effects' after investor buyout bid
Quince Therapeutics’ board has put in place a stock plan to defend it against an unsolicited takeover, the company announced Wednesday.
Known as a poison …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
